Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial
Abstract Background Ultrafiltration decreases total body water and improves the alveolar to arterial oxygen gradient. The aims of the study were to investigate the efficacy and safety of early ultrafiltration in acute decompensated heart failure (ADHF) patients. Methods 100 patients with ADHF within...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2020-10-01
|
| Series: | BMC Cardiovascular Disorders |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s12872-020-01733-5 |
| _version_ | 1819046239959777280 |
|---|---|
| author | Jingyi Hu Qianli Wan Yue Zhang Jun Zhou Miaomiao Li Li Jiang Fang Yuan |
| author_facet | Jingyi Hu Qianli Wan Yue Zhang Jun Zhou Miaomiao Li Li Jiang Fang Yuan |
| author_sort | Jingyi Hu |
| collection | DOAJ |
| description | Abstract Background Ultrafiltration decreases total body water and improves the alveolar to arterial oxygen gradient. The aims of the study were to investigate the efficacy and safety of early ultrafiltration in acute decompensated heart failure (ADHF) patients. Methods 100 patients with ADHF within 24 h of admission were randomly assigned into early ultrafiltration (n = 40) or torasemide plus tolvaptan (n = 60) groups. The primary outcomes were weight loss and an increase in urine output on days 4 and 8 of treatment. Results Patients who received early ultrafiltration for 3 days achieved a greater weight loss (kg) (− 2.94 ± 3.76 vs − 0.64 ± 0.91, P < 0.001) and urine increase (mL) (198.00 ± 170.70 vs 61.77 ± 4.67, P < 0.001) than the torasemide plus tolvaptan group on day 4. From days 4 to 7, patients in the early ultrafiltration group received sequential therapy of torasemide and tolvaptan. Better control of volume was reflected in a greater weight loss (− 3.72 ± 3.81 vs − 1.34 ± 1.32, P < 0.001) and urine increase (373.80 ± 120.90 vs 79.5 ± 52.35, P < 0.001), greater reduction of B-type natriuretic peptide (BNP) (pg/mL) (− 1144 ± 1435 vs − 654.02 ± 889.65, P = 0.037), NYHA (New York Heart Association) functional class (− 1.45 ± 0.50 vs − 1.17 ± 0.62, P = 0.018), jugular venous pulse (JVP) score (points) (− 1.9 ± 1.13 vs − 0.78 ± 0.69, P < 0.001), inferior vena cava (IVC) diameter (mm) (− 15.35 ± 11.03 vs − 4.98 ± 6.00, P < 0.001) and an increase in the dyspnea score (points) (4.08 ± 3.44 vs 2.77 ± 2.03, P = 0.035) in the early ultrafiltration group on day 8. No significant differences were found in the readmission and mortality rates in the 2 patient groups at the 1-month and 3-month follow-ups. Both groups had a similar stable renal profile. Conclusion Early ultrafiltration is superior to diuretics for volume overload treatment initiation of ADHF patients. Trial registration Chinese Clinical Trial Registry, ChiCTR2000030696, Registered 10 March 2020—Retrospectively registered, https://www.chictr.org.cn/showproj.aspx?proj=29099 . |
| first_indexed | 2024-12-21T10:41:19Z |
| format | Article |
| id | doaj.art-0e80ee7d31304c5da75cc4fb0efd98ca |
| institution | Directory Open Access Journal |
| issn | 1471-2261 |
| language | English |
| last_indexed | 2024-12-21T10:41:19Z |
| publishDate | 2020-10-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Cardiovascular Disorders |
| spelling | doaj.art-0e80ee7d31304c5da75cc4fb0efd98ca2022-12-21T19:06:55ZengBMCBMC Cardiovascular Disorders1471-22612020-10-0120111110.1186/s12872-020-01733-5Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trialJingyi Hu0Qianli Wan1Yue Zhang2Jun Zhou3Miaomiao Li4Li Jiang5Fang Yuan6Department of Critical Care Medicine (Specialty of Heart Failure), Tongren Hospital, Shanghai Jiaotong University School of MedicineDepartment of Critical Care Medicine (Specialty of Heart Failure), Tongren Hospital, Shanghai Jiaotong University School of MedicineDepartment of Critical Care Medicine (Specialty of Heart Failure), Tongren Hospital, Shanghai Jiaotong University School of MedicineDepartment of Cardiology, Tongren Hospital, Shanghai Jiaotong University School of MedicineDepartment of Critical Care Medicine (Specialty of Heart Failure), Tongren Hospital, Shanghai Jiaotong University School of MedicineDepartment of Cardiology, Tongren Hospital, Shanghai Jiaotong University School of MedicineDepartment of Critical Care Medicine (Specialty of Heart Failure), Tongren Hospital, Shanghai Jiaotong University School of MedicineAbstract Background Ultrafiltration decreases total body water and improves the alveolar to arterial oxygen gradient. The aims of the study were to investigate the efficacy and safety of early ultrafiltration in acute decompensated heart failure (ADHF) patients. Methods 100 patients with ADHF within 24 h of admission were randomly assigned into early ultrafiltration (n = 40) or torasemide plus tolvaptan (n = 60) groups. The primary outcomes were weight loss and an increase in urine output on days 4 and 8 of treatment. Results Patients who received early ultrafiltration for 3 days achieved a greater weight loss (kg) (− 2.94 ± 3.76 vs − 0.64 ± 0.91, P < 0.001) and urine increase (mL) (198.00 ± 170.70 vs 61.77 ± 4.67, P < 0.001) than the torasemide plus tolvaptan group on day 4. From days 4 to 7, patients in the early ultrafiltration group received sequential therapy of torasemide and tolvaptan. Better control of volume was reflected in a greater weight loss (− 3.72 ± 3.81 vs − 1.34 ± 1.32, P < 0.001) and urine increase (373.80 ± 120.90 vs 79.5 ± 52.35, P < 0.001), greater reduction of B-type natriuretic peptide (BNP) (pg/mL) (− 1144 ± 1435 vs − 654.02 ± 889.65, P = 0.037), NYHA (New York Heart Association) functional class (− 1.45 ± 0.50 vs − 1.17 ± 0.62, P = 0.018), jugular venous pulse (JVP) score (points) (− 1.9 ± 1.13 vs − 0.78 ± 0.69, P < 0.001), inferior vena cava (IVC) diameter (mm) (− 15.35 ± 11.03 vs − 4.98 ± 6.00, P < 0.001) and an increase in the dyspnea score (points) (4.08 ± 3.44 vs 2.77 ± 2.03, P = 0.035) in the early ultrafiltration group on day 8. No significant differences were found in the readmission and mortality rates in the 2 patient groups at the 1-month and 3-month follow-ups. Both groups had a similar stable renal profile. Conclusion Early ultrafiltration is superior to diuretics for volume overload treatment initiation of ADHF patients. Trial registration Chinese Clinical Trial Registry, ChiCTR2000030696, Registered 10 March 2020—Retrospectively registered, https://www.chictr.org.cn/showproj.aspx?proj=29099 .http://link.springer.com/article/10.1186/s12872-020-01733-5Early ultrafiltrationHeart failureFluid overloadLoop diureticsSequential therapy |
| spellingShingle | Jingyi Hu Qianli Wan Yue Zhang Jun Zhou Miaomiao Li Li Jiang Fang Yuan Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial BMC Cardiovascular Disorders Early ultrafiltration Heart failure Fluid overload Loop diuretics Sequential therapy |
| title | Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial |
| title_full | Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial |
| title_fullStr | Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial |
| title_full_unstemmed | Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial |
| title_short | Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial |
| title_sort | efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload a prospective randomized controlled clinical trial |
| topic | Early ultrafiltration Heart failure Fluid overload Loop diuretics Sequential therapy |
| url | http://link.springer.com/article/10.1186/s12872-020-01733-5 |
| work_keys_str_mv | AT jingyihu efficacyandsafetyofearlyultrafiltrationinpatientswithacutedecompensatedheartfailurewithvolumeoverloadaprospectiverandomizedcontrolledclinicaltrial AT qianliwan efficacyandsafetyofearlyultrafiltrationinpatientswithacutedecompensatedheartfailurewithvolumeoverloadaprospectiverandomizedcontrolledclinicaltrial AT yuezhang efficacyandsafetyofearlyultrafiltrationinpatientswithacutedecompensatedheartfailurewithvolumeoverloadaprospectiverandomizedcontrolledclinicaltrial AT junzhou efficacyandsafetyofearlyultrafiltrationinpatientswithacutedecompensatedheartfailurewithvolumeoverloadaprospectiverandomizedcontrolledclinicaltrial AT miaomiaoli efficacyandsafetyofearlyultrafiltrationinpatientswithacutedecompensatedheartfailurewithvolumeoverloadaprospectiverandomizedcontrolledclinicaltrial AT lijiang efficacyandsafetyofearlyultrafiltrationinpatientswithacutedecompensatedheartfailurewithvolumeoverloadaprospectiverandomizedcontrolledclinicaltrial AT fangyuan efficacyandsafetyofearlyultrafiltrationinpatientswithacutedecompensatedheartfailurewithvolumeoverloadaprospectiverandomizedcontrolledclinicaltrial |